These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36183863)
21. Cognitive behavioral therapy for substance use disorders. McHugh RK; Hearon BA; Otto MW Psychiatr Clin North Am; 2010 Sep; 33(3):511-25. PubMed ID: 20599130 [TBL] [Abstract][Full Text] [Related]
22. Cognition and addiction . Verdejo-Garcia A; Garcia-Fernandez G; Dom G Dialogues Clin Neurosci; 2019 Sep; 21(3):281-290. PubMed ID: 31749652 [TBL] [Abstract][Full Text] [Related]
23. The effectiveness of attentional bias modification for substance use disorder symptoms in adults: a systematic review. Heitmann J; Bennik EC; van Hemel-Ruiter ME; de Jong PJ Syst Rev; 2018 Oct; 7(1):160. PubMed ID: 30316302 [TBL] [Abstract][Full Text] [Related]
24. [Cognitive and Cognitive-Behavioral Therapy for substance abuse disorders]. Silva CJ; Serra AM Braz J Psychiatry; 2004 May; 26 Suppl 1():S33-9. PubMed ID: 15729442 [TBL] [Abstract][Full Text] [Related]
25. The Effectiveness of Cognitive Bias Modification Interventions for Substance Addictions: A Meta-Analysis. Cristea IA; Kok RN; Cuijpers P PLoS One; 2016; 11(9):e0162226. PubMed ID: 27611692 [TBL] [Abstract][Full Text] [Related]
27. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742 [TBL] [Abstract][Full Text] [Related]
28. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? Roth RM; Brunette MF; Green AI Curr Psychiatry Rep; 2005 Aug; 7(4):283-91. PubMed ID: 16098282 [TBL] [Abstract][Full Text] [Related]
29. Theory-based active ingredients of effective treatments for substance use disorders. Moos RH Drug Alcohol Depend; 2007 May; 88(2-3):109-21. PubMed ID: 17129682 [TBL] [Abstract][Full Text] [Related]
30. Protocol for a randomised controlled trial of cognitive bias modification training during inpatient withdrawal from alcohol use disorder. Manning V; Garfield JBB; Campbell SC; Reynolds J; Staiger PK; Lum JAG; Hall K; Wiers RW; Lubman DI; Verdejo-Garcia A Trials; 2018 Nov; 19(1):598. PubMed ID: 30382877 [TBL] [Abstract][Full Text] [Related]
31. Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention. Rezapour T; DeVito EE; Sofuoglu M; Ekhtiari H Prog Brain Res; 2016; 224():345-69. PubMed ID: 26822366 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. Schierenberg A; van Amsterdam J; van den Brink W; Goudriaan AE Curr Drug Abuse Rev; 2012 Dec; 5(4):320-31. PubMed ID: 23244344 [TBL] [Abstract][Full Text] [Related]
33. Outcome predictors in substance use disorders. Ciraulo DA; Piechniczek-Buczek J; Iscan EN Psychiatr Clin North Am; 2003 Jun; 26(2):381-409. PubMed ID: 12778840 [TBL] [Abstract][Full Text] [Related]
34. [Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder]. Moggi F Ther Umsch; 2018 Jun; 75(1):37-43. PubMed ID: 29909760 [TBL] [Abstract][Full Text] [Related]
35. [Theoretical reflection on the place of memory and temporal cognitive mechanisms in addictive disorders]. Lalanne L; Laprevote V; Danion JM; Bacon E Encephale; 2016 Jun; 42(3):264-9. PubMed ID: 26875869 [TBL] [Abstract][Full Text] [Related]
36. Common and distinct neural targets of treatment: changing brain function in substance addiction. Konova AB; Moeller SJ; Goldstein RZ Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2806-17. PubMed ID: 24140399 [TBL] [Abstract][Full Text] [Related]
37. The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders. Hoppes K CNS Spectr; 2006 Nov; 11(11):829-51. PubMed ID: 17075556 [TBL] [Abstract][Full Text] [Related]
39. Exercise as a Sex-Specific Treatment for Substance Use Disorder. Lynch WJ; Abel J; Robinson AM; Smith MA Curr Addict Rep; 2017 Dec; 4(4):467-481. PubMed ID: 29404264 [TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. McGovern MP; Lambert-Harris C; Xie H; Meier A; McLeman B; Saunders E Addiction; 2015 Jul; 110(7):1194-204. PubMed ID: 25846251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]